Introduction: Pre-exposure prophylaxis (PrEP) has demonstrated strong efficacy in reducing HIV risk among men who have sex with men (MSM), transgender women, and heterosexual populations (1). With the rise of biomedical HIV prevention strategies, Descovy (tenofovir alafenamide/emtricitabine/ TAF) has emerged as a promising alternative to Truvada (t
482 Reached1 Comments
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7715 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Rubella Syndrome in Neonate
1394 Reached12 Comments9 Likes